Prosecution Insights
Last updated: April 19, 2026

Uva-Jenkins, Taylor & Hunt

39 pending office actions • 9 clients

Portfolio Summary

39
Total Pending OAs
13
Final Rejections
26
Non-Final OAs

Client Portfolio (9 clients)

Client (Assignee)Pending OAs
UNIVERSITY OF VIRGINIA PATENT FOUNDATION 31
Georgia Tech Research Corporation 1
Old Dominion University Research Foundation 1
The University of Manchester 1
VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 1
Elias Reichel 1
UNIVERSITY OF UTAH RESEARCH FOUNDATION 1
Wayne State University 1
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19271944 COMPOSITIONS AND METHODS FOR DETECTING AND REGULATING FIBRONECTIN-INTEGRIN INTERACTION AND SIGNALING Georgia Tech Research Corporation HADDAD, MAHER M 1641 Non-Final OA Jul 17, 2025
18685194 SULFONYL-TRIAZOLES USEFUL AS COVALENT KINASE LIGANDS UNIVERSITY OF VIRGINIA PATENT FOUNDATION MOORE, SUSANNA 1624 Non-Final OA Feb 20, 2024
18684813 SYSTEMS, METHODS, AND COMPUTER READABLE MEDIA FOR PARAMETRIC FDG PET QUANTIFICATION, SEGMENTATION AND CLASSIFICATION OF ABNORMALITIES UNIVERSITY OF VIRGINIA PATENT FOUNDATION MEHL, PATRICK M 3798 Final Rejection Feb 19, 2024
18566497 MINICELLS FROM HIGHLY GENOME REDUCED ESCHERICHIA COLI: CYTOPLASMIC AND SURFACE EXPRESSION OF RECOMBINANT PROTEINS AND INCORPORATION IN THE MINICELLS UNIVERSITY OF VIRGINIA PATENT FOUNDATION GANGLE, BRIAN J 1645 Non-Final OA Dec 01, 2023
18495741 SUGAR-CONJUGATED LIPID NANOPARTICLES AND METHODS OF USE THEREFOR UNIVERSITY OF VIRGINIA PATENT FOUNDATION REGA, KYLE THOMAS 1636 Non-Final OA Oct 26, 2023
18286976 COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING LUNG INJURY Old Dominion University Research Foundation DEKARSKE, MADELINE MCGUIRE 1622 Non-Final OA Oct 13, 2023
18281528 COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING THERAPY-RELATED CARDIOMYOPATHY ASSOCIATED WITH NEUTROPHIL INFILTRATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION YOO, SUN JAE 1621 Non-Final OA Sep 11, 2023
18277676 GUEST-HOST SUPRAMOLECULAR ASSEMBLY OF INJECTABLE HYDROGEL NANOFIBERS FOR CELL ENCAPSULATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION BERKE-SCHLESSEL, DAVID W 1651 Non-Final OA Aug 17, 2023
18277752 THE COMBINED INFLUENCE OF VISCOELASTIC AND ADHESIVE CUES ON FIBROBLAST SPREADING AND FOCAL ADHESION FORMATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION GULLEDGE, BRIAN M 1699 Non-Final OA Aug 17, 2023
18273658 METHODS AND SYSTEMS FOR PRODUCING DISPERSED GRAPHENE FROM SPENT LITHIUM-ION BATTERIES UNIVERSITY OF VIRGINIA PATENT FOUNDATION IQBAL, SYED TAHA 1736 Non-Final OA Jul 21, 2023
18269147 HYALURONAN IS A DRIVER OF COVID-19 SEVERITY The University of Manchester SCHACHERMEYER, SAMANTHA LYNN 1693 Non-Final OA Jun 22, 2023
18037684 MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME UNIVERSITY OF VIRGINIA PATENT FOUNDATION LIPPERT, JOHN WILLIAM 1615 Non-Final OA May 18, 2023
18316981 COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY UNIVERSITY OF VIRGINIA PATENT FOUNDATION HUDSON, AMY ROSE 1636 Final Rejection May 12, 2023
18031969 COMPOSITIONS AND METHODS FOR OVERCOMING DR5-INDUCED IMMUNE EVASION BY SOLID TUMORS UNIVERSITY OF VIRGINIA PATENT FOUNDATION SHUPE, ELIZABETH A 1643 Non-Final OA Apr 14, 2023
18027202 3D-PRINTED MODULAR MICROCHIP WITH AN INTEGRATED IMPELLER PUMP TO MODEL INTER-ORGAN COMMUNICATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION GIERE, REBECCA M 1677 Non-Final OA Mar 20, 2023
18018469 METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR ANALYZING RESPIRATORY KINEMATICS UNIVERSITY OF VIRGINIA PATENT FOUNDATION MONTGOMERY, MELISSA JO 3791 Final Rejection Jan 27, 2023
18011412 TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19 UNIVERSITY OF VIRGINIA PATENT FOUNDATION KIM, YUNSOO 1641 Final Rejection Dec 19, 2022
17924963 COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST CLASS I FUSION PROTEIN VIRUSES VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. SINGH, SATYENDRA K 1657 Non-Final OA Nov 11, 2022
17917407 COMPOSITIONS AND METHODS FOR TREATING VIRUSES Elias Reichel PALLAY, MICHAEL B 1617 Final Rejection Oct 06, 2022
17912805 NRTIS, NRTI METABOLITES, AND NRTI ANALOGS FOR MACULAR DEGENERATION AND VIRAL INFECTIONS UNIVERSITY OF VIRGINIA PATENT FOUNDATION BRANDSEN, BENJAMIN MICHAEL 1693 Final Rejection Sep 19, 2022
17910613 METABOLITES RELEASED FROM APOPTOTIC CELLS ACT AS NOVEL TISSUE MESSENGERS UNIVERSITY OF VIRGINIA PATENT FOUNDATION BARSKY, JARED 1628 Non-Final OA Sep 09, 2022
17800387 CAR T CELLS TARGETING THE INTEGRIN ALPHAV BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES UNIVERSITY OF VIRGINIA PATENT FOUNDATION BELYAVSKYI, MICHAIL A 1644 Non-Final OA Aug 17, 2022
17799149 COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS UNIVERSITY OF VIRGINIA PATENT FOUNDATION ADLAM, CHANTAL PETA-GAYE 1622 Final Rejection Aug 11, 2022
17776563 OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION UNIVERSITY OF UTAH RESEARCH FOUNDATION MONTANARI, DAVID A 1632 Non-Final OA May 12, 2022
17775213 CERAMIDE ANALOG SACLAC MODULATES SPHINGOLIPID LEVELS AND MCL-1 SPLICING TO INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA UNIVERSITY OF VIRGINIA PATENT FOUNDATION SCHACHERMEYER, SAMANTHA LYNN 1693 Non-Final OA May 06, 2022
17769907 CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS UNIVERSITY OF VIRGINIA PATENT FOUNDATION NGUYEN, NGOC-ANH THI 1615 Non-Final OA Apr 18, 2022
17769899 COMPOSITIONS AND METHODS FOR PRODUCING ENHANCED IMMUNE RESPONSES AND RAPID ANTIBODY PRODUCTION UNIVERSITY OF VIRGINIA PATENT FOUNDATION MORGAN, BAILEY MICHELLE 1645 Non-Final OA Apr 18, 2022
17637557 DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASES UNIVERSITY OF VIRGINIA PATENT FOUNDATION GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 Non-Final OA Feb 23, 2022
17629303 CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION JARRELL, NOBLE E 1699 Final Rejection Jan 21, 2022
17436882 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE UNIVERSITY OF VIRGINIA PATENT FOUNDATION RAMOS LEWIS, JOSMALEN MILAGROS 1621 Final Rejection Sep 07, 2021
17434692 INDUCTION OF HIGHLY EFFICACIOUS ANTI-TUMOR AND IMMUNE MODULATING ACTIVITY: CELL-FREE OFF THE SHELF THERAPEUTIC MODALITY Wayne State University BUTTICE, AUDREY L 1647 Non-Final OA Aug 27, 2021
17429745 SELECTION AND BLOCKADE OF FERTILIZATION COMPETENT MALE AND FEMALE GAMETES UNIVERSITY OF VIRGINIA PATENT FOUNDATION KIRWIN, STEFANIE JOHANNA 1677 Non-Final OA Aug 10, 2021
17311624 COMPOSITIONS AND METHODS FOR REGULATING INFLAMMATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION KUCHARCZK, JED A 1623 Final Rejection Jun 07, 2021
17283626 ENDOGENOUS CYTOPLASMIC ALU COMPLEMENTARY DNA IN AGE-RELATED MACULAR DEGENERATION UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION MCLEOD, AFRICA MHAIRIE 1635 Non-Final OA Apr 08, 2021
17272199 COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING VIRUS INFECTION UNIVERSITY OF VIRGINIA PATENT FOUNDATION FOLEY, SHANON A 1671 Final Rejection Feb 26, 2021
17050231 COMPOSITIONS AND METHODS FOR TREATING ABDOMINAL AORTIC ANEURYSM UNIVERSITY OF VIRGINIA PATENT FOUNDATION SHUPE, ELIZABETH A 1643 Non-Final OA Oct 23, 2020
16921366 COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE UNIVERSITY OF VIRGINIA PATENT FOUNDATION PALLAY, MICHAEL B 1617 Final Rejection Jul 06, 2020
16669191 COMPOSITIONS AND METHODS FOR TREATING CANCER UNIVERSITY OF VIRGINIA PATENT FOUNDATION RAHMAN, MASUDUR 1633 Non-Final OA Oct 30, 2019
16097024 SYSTEMS, METHODS, AND COMPUTER READABLE MEDIA FOR ISCHEMIC INJURY PROTECTIVE ULTRASOUND UNIVERSITY OF VIRGINIA PATENT FOUNDATION COOK, CHRISTOPHER L 3797 Final Rejection Oct 26, 2018

Managing Uva-Jenkins, Taylor & Hunt's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month